NCT05834010

Brief Summary

The investigators hypothesize that prolonged undernutrition in anorexia nervosa alters the microbiome to a different steady-state (dysbiotic) composition that sustains the disease, even after returning to normal diet. The investigators propose that transplanting a fully ecologically functioning GM from a healthy donor, through a FMT, can reboot the gut-brain-axis, ameliorate symptoms and improve clinical outcomes. To approach this, in the challenging AN patient group, the investigators want to conduct a FMT feasibility/pilot study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at P25-P50 for early_phase_1

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

March 18, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 27, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

June 27, 2025

Status Verified

June 1, 2025

Enrollment Period

1.8 years

First QC Date

March 18, 2023

Last Update Submit

June 24, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility of FMT in AN patients

    The recruitment and compliance of 10-20 patients/year is feasible

    2 years

  • Preferred route of FMT (questionnaire)

    FMT is offered as a Capsule-treatment orally or as an enema-rectally

    2 years

Secondary Outcomes (7)

  • A single FMT treatment can alter GM composition in AN patients short term

    2 yrs

  • A single FMT treatment can alter gut brain signaling in serum. might changes serum signal molecules related to appetite and metabolism with in same patien

    2 yrs

  • A single FMT treatment can alter gut brain signaling in serum. might changes serum signal molecules related to appetite and metabolism with in same patien

    2 yrs

  • A single FMT treatment can alter gut brain signaling in serum. might changes serum signal molecules related to appetite and metabolism with in same patien

    2 yrs

  • A single FMT treatment can alter gut brain signaling in serum. might changes serum signal molecules related to appetite and metabolism with in same patien

    2 yrs

  • +2 more secondary outcomes

Other Outcomes (1)

  • FMT questionnaires

    2 yrs

Study Arms (1)

FMT

EXPERIMENTAL

rectal or oral route FMT

Biological: Fecal Microbiome Transplant

Interventions

Fecal matter from healthy age/sex matched established and screened donors, recruited from the Danish Blood-donor system

Also known as: Fecal Matter Transplant
FMT

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Age \<18 years. Known ongoing abuse of laxatives.
  • Antibiotic treatment within the last three months.
  • Probiotics within the last month
  • Inflammatory bowel disease, colorectal cancer or other known chronic bowel disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Psychiatric Centre Ballerup

Ballerup Municipality, Denmark, 2750, Denmark

Location

Copenhagen University Hospital Hvidovre

Hvidovre, Denmark, 2650, Denmark

Location

Odense University Hospital

Odense, 5000, Denmark

Location

Related Publications (1)

  • Panah FM, Stoving RK, Sjogren M, Micali N, Maschek S, Reis KD, Mirsepasi-Lauridsen HC, Petersen AM, Nielsen DS, Helms M, Rasmussen MA, Barfod KK. Impact of a single fecal microbiome transplantation in adult women with anorexia nervosa: an open-label feasibility pilot trial. Nat Commun. 2026 Jan 14. doi: 10.1038/s41467-026-68455-8. Online ahead of print.

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: 1 single FMT event either oral route or rectal. Sampling fecal matter and blood at baseline and 1 week after FMT.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. MD pHD Clinical Associate Research Professor

Study Record Dates

First Submitted

March 18, 2023

First Posted

April 27, 2023

Study Start

March 18, 2023

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

June 27, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations